Thomas Schön
About
Thomas Schön is a scholar working on Infectious Diseases, Epidemiology and Pharmacology.
According to data from OpenAlex, Thomas Schön has authored 121 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Infectious Diseases, 78 papers in Epidemiology and 18 papers in Pharmacology. Recurrent topics in Thomas Schön's work include Tuberculosis Research and Epidemiology (89 papers), Mycobacterium research and diagnosis (41 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Thomas Schön is often cited by papers focused on Tuberculosis Research and Epidemiology (89 papers), Mycobacterium research and diagnosis (41 papers) and Pneumocystis jirovecii pneumonia detection and treatment (26 papers). Thomas Schön collaborates with scholars based in Sweden, Ethiopia and Denmark. Thomas Schön's co-authors include Christian Wejse, Victor Næstholt Dahl, Sven Britton, Kristian Ängeby, Pontus Juréen, Erik Sturegård, Erja Chryssanthou, Olle Stendahl, Gunnar Kahlmeter and Christian G. Giske and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.
In The Last Decade
Thomas Schön
117 papers receiving 2.9k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas Schön Sweden | 30 | 2.2k | 1.7k | 611 | 446 | 287 | 121 | 2.9k | ||
| Richard Hafner United States | 40 | 3.4k 1.6× | 3.7k 2.1× | 722 1.2× | 491 1.1× | 547 1.9× | 86 | 5.2k | ||
| Simon Tiberi United Kingdom | 29 | 2.2k 1.0× | 1.4k 0.8× | 740 1.2× | 618 1.4× | 77 0.3× | 84 | 3.0k | ||
| Amita Jain India | 37 | 2.0k 0.9× | 1.5k 0.9× | 748 1.2× | 667 1.5× | 112 0.4× | 214 | 4.2k | ||
| Tim Planche United Kingdom | 31 | 1.7k 0.8× | 1.4k 0.8× | 295 0.5× | 400 0.9× | 233 0.8× | 94 | 3.3k | ||
| John L. Ho United States | 31 | 2.0k 0.9× | 2.1k 1.2× | 771 1.3× | 442 1.0× | 184 0.6× | 72 | 3.8k | ||
| Srikanth Tripathy India | 36 | 2.6k 1.2× | 1.5k 0.9× | 600 1.0× | 440 1.0× | 203 0.7× | 236 | 4.2k | ||
| Tran Thi Hong Chau Vietnam | 38 | 2.0k 0.9× | 1.6k 0.9× | 1.7k 2.9× | 434 1.0× | 271 0.9× | 77 | 5.0k | ||
| Luciano Zubaran Goldani Brazil | 27 | 1.3k 0.6× | 1.4k 0.8× | 136 0.2× | 465 1.0× | 171 0.6× | 125 | 3.2k | ||
| Harald Hoffmann Germany | 27 | 1.4k 0.6× | 1.3k 0.8× | 539 0.9× | 562 1.3× | 66 0.2× | 76 | 2.6k | ||
| Dionysios Neofytos Switzerland | 30 | 3.4k 1.6× | 3.2k 1.9× | 237 0.4× | 296 0.7× | 79 0.3× | 120 | 4.5k |
Countries citing papers authored by Thomas Schön
Since
Specialization
Citations
This map shows the geographic impact of Thomas Schön's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schön with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schön more than expected).
Fields of papers citing papers by Thomas Schön
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Thomas Schön. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schön. The network helps show where Thomas Schön may publish in the future.
Co-authorship network of co-authors of Thomas Schön
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schön. A scholar is included among the top collaborators of Thomas Schön based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schön. Thomas Schön is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Folkesson, Elin, Gabrielle Fröberg, Christopher Sundling, et al.. (2025). Improved Detection of Extrapulmonary and Paucibacillary Pulmonary Tuberculosis by Xpert MTB Host Response in a Tuberculosis Low-Endemic, High-Resource Setting. The Journal of Infectious Diseases. 232(1). e78–e88.
2.
Forsman, Lina Davies, Jerker Jonsson, Ramona Groenheit, et al.. (2024). Increased risk of adverse drug reactions by higher linezolid dose per weight in multidrug-resistant tuberculosis. International Journal of Antimicrobial Agents. 64(4). 107302–107302.
3.
Miotto, Paolo, Daniela María Cirillo, Thomas Schön, & Claudio U. Köser. (2024). The exceptions that prove the rule—a historical view of bedaquiline susceptibility. Genome Medicine. 16(1). 39–39.
4.
Schön, Thomas, et al.. (2023). No impact of helminth coinfection in patients with smear positive tuberculosis on immunoglobulin levels using a novel method measuring Mycobacterium tuberculosis-specific antibodies. Allergy Asthma and Clinical Immunology. 19(1). 55–55.
5.
Vilchèze, Catherine, Jim Werngren, Arnold Bainomugisa, et al.. (2023). Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 68(1). e0109623–e0109623.
6.
Schön, Thomas, et al.. (2023). Is there a need to optimise pyrazinamide doses in patients with tuberculosis? A systematic review. International Journal of Antimicrobial Agents. 62(3). 106914–106914.
7.
Fröberg, Gabrielle, Erja Chryssanthou, Michael Runold, et al.. (2023). A Rough Colony Morphology ofMycobacterium abscessusIs Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome. The Journal of Infectious Diseases. 227(6). 820–827.
8.
Andersson, Blanka, et al.. (2020). A novel mycobacterial growth inhibition assay employing live-cell imaging of virulent M. tuberculosis and monitoring of host cell viability. Tuberculosis. 124. 101977–101977.
9.
Togarsimalemath, Shambhuprasad Kotresh, et al.. (2020). Helminth Antigen Exposure Enhances Early Immune Control of Mycobacterium tuberculosis in Monocytes and Macrophages. Journal of Innate Immunity. 13(3). 148–163.
10.
Schön, Thomas, Erika Matuschek, Mrudula Utukuri, et al.. (2019). Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex. Clinical Microbiology and Infection. 25(4). 403–405.
11.
Heyckendorf, Jan, Sönke Andres, Claudio U. Köser, et al.. (2017). What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrobial Agents and Chemotherapy. 62(2).
12.
Yu, Xia, Guirong Wang, Suting Chen, et al.. (2016). Wild-Type and Non-Wild-Type Mycobacterium tuberculosis MIC Distributions for the Novel Fluoroquinolone Antofloxacin Compared with Those for Ofloxacin, Levofloxacin, and Moxifloxacin. Antimicrobial Agents and Chemotherapy. 60(9). 5232–5237.
13.
Akuffo, Hannah, Sven Britton, & Thomas Schön. (2015). Worms and Humans: A Happy Divorce?. PubMed. 6(1-2). 27–32.
14.
Larsson, Marie, et al.. (2014). Rapid identification of pneumococci, enterococci, beta-haemolytic streptococci and S. aureusfrom positive blood cultures enabling early reports. BMC Infectious Diseases. 14(1). 146–146.
15.
Sturegård, Erik, Kristian Ängeby, Jim Werngren, et al.. (2014). Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10. Clinical Microbiology and Infection. 21(2). 148.e5–148.e7.
16.
Eklund, Daniel, Marie Larsson, Amanda Welin, et al.. (2013). Alveolar macrophages from patients with tuberculosis exhibit reduced capacity of restricting growth of Mycobacterium tuberculosis: a pilot study of vitamin D stimulation in vitro. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1(1). 6–6.
17.
Gelaw, Aschalew, et al.. (2012). Plasma IgE level and Eosinophil count in smear positive tuberculosis patientswith and without helminthic infections at Gondar University Hospital,Northwest Ethiopia. European Journal of Experimental Biology. 2(6).
18.
Schön, Thomas, Rogélio Hernández‐Pando, Yohannes Negesse, et al.. (2004). Nitrotyrosine localization to dermal nerves in borderline leprosy. British Journal of Dermatology. 150(3). 570–574.
19.
Schön, Thomas, Feleke Moges, Endalkachew Belayneh Melese, et al.. (2003). Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis. European Respiratory Journal. 21(3). 483–488.
20.
Schön, Thomas, et al.. (2000). High dose prednisolone treatment of leprosy patients undergoing reactions is associated with a rapid decrease in urinary nitric oxide metabolites and clinical improvement. Leprosy Review. 71(3). 355–62.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Richard Hafner Breakdown of academic impact, for papers by Simon Tiberi Breakdown of academic impact, for papers by Amita Jain Breakdown of academic impact, for papers by Tim Planche Breakdown of academic impact, for papers by John L. Ho Breakdown of academic impact, for papers by Srikanth Tripathy Breakdown of academic impact, for papers by Tran Thi Hong Chau Breakdown of academic impact, for papers by Luciano Zubaran Goldani Breakdown of academic impact, for papers by Harald Hoffmann Breakdown of academic impact, for papers by Dionysios Neofytos